1: Narayan A, Patel S, Baile SB, Jain S, Sharma S. Imidazo[1,2-A]Pyridine: Potent Biological Activity, SAR and Docking Investigations (2017-2022). Infect Disord Drug Targets. 2024;24(8):e200324228067. doi: 10.2174/0118715265274067240223040333. PMID: 38509674.
2: Kamboj P, Tyagi V. Enzymatic Synthesis of Indole-Based Imidazopyridine using α-Amylase. Chembiochem. 2024 Mar 15;25(6):e202300824. doi: 10.1002/cbic.202300824. Epub 2024 Feb 20. PMID: 38279707.
3: Tyagi S, Mishra R, Mazumder R, Mazumder A. Current Market Potential and Prospects of Copper-based Pyridine Derivatives: A Review. Curr Mol Med. 2024;24(9):1111-1123. doi: 10.2174/1566524023666230726160056. PMID: 37496249.
4: Guo L, Ding Y, Wang H, Liu Y, Qiang Q, Luo Q, Song F, Li C. Imidazo[1,2-a]pyridine derivatives synthesis from lignin β-O-4 segments via a one-pot multicomponent reaction. iScience. 2023 May 9;26(6):106834. doi: 10.1016/j.isci.2023.106834. PMID: 37250767; PMCID: PMC10209544.
5: Tali JA, Shankar R. Ru(II)-Catalyzed Synthesis of Fused Imidazo[1,2-a]pyridine-chromenones and Methylene-Tethered Bis- imidazo[1,2-a]pyridines and Regioselective O-Acetoxylation of Imidazo[1,2-a]pyridines. Org Lett. 2023 May 12;25(18):3200-3205. doi: 10.1021/acs.orglett.3c00578. Epub 2023 May 4. PMID: 37140128.
6: Prasher P, Sharma M, Sharma M, Rawat DS. C3 regioselectivity: a major constraint in the drug development with imidazo[1,2-a]pyridines. Future Med Chem. 2022 Nov;14(21):1491-1494. doi: 10.4155/fmc-2022-0148. Epub 2022 Oct 3. PMID: 36189868.
7: Zozik Y, Sevim M, Lafzi F, Kilic H, Metin Ö. Magnetically recoverable nickel- palladium alloy nanocatalysts for direct C-H arylation reactions. Dalton Trans. 2021 Dec 7;50(47):17515-17523. doi: 10.1039/d1dt02985a. PMID: 34762086.
8: Tali JA, Kumar G, Singh D, Shankar R. Palladium(II) catalyzed site-selective C-H olefination of imidazo[1,2-a]pyridines. Org Biomol Chem. 2021 Nov 10;19(43):9401-9406. doi: 10.1039/d1ob01683k. PMID: 34705920.
9: Ghosh S, Khandelia T, Patel BK. Solvent-Switched Manganese(I)-Catalyzed Regiodivergent Distal vs Proximal C-H Alkylation of Imidazopyridine with Maleimide. Org Lett. 2021 Oct 1;23(19):7370-7375. doi: 10.1021/acs.orglett.1c02536. Epub 2021 Sep 20. PMID: 34543041.
10: Bhutia ZT, Panjikar PC, Iyer S, Chatterjee A, Banerjee M. Iodine Promoted Efficient Synthesis of 2-Arylimidazo[1,2-a]pyridines in Aqueous Media: A Comparative Study between Micellar Catalysis and an "On-Water" Platform. ACS Omega. 2020 May 26;5(22):13333-13343. doi: 10.1021/acsomega.0c01478. PMID: 32548520; PMCID: PMC7288711.
11: Samanta SK, Bera MK. Iodine mediated oxidative cross coupling of 2-aminopyridine and aromatic terminal alkyne: a practical route to imidazo[1,2-a]pyridine derivatives. Org Biomol Chem. 2019 Jul 14;17(26):6441-6449. doi: 10.1039/c9ob00812h. Epub 2019 Jun 17. Erratum in: Org Biomol Chem. 2019 Aug 7;17(31):7425. doi: 10.1039/c9ob90125f. PMID: 31206121.
12: Zhou G, Tian Y, Zhao X, Dan W. Selective Fluorination of 4-Substituted 2-Aminopyridines and Pyridin-2(1 H)-ones in Aqueous Solution. Org Lett. 2018 Aug 17;20(16):4858-4861. doi: 10.1021/acs.orglett.8b02003. Epub 2018 Aug 7. PMID: 30085670.
13: Deep A, Bhatia RK, Kaur R, Kumar S, Jain UK, Singh H, Batra S, Kaushik D, Deb PK. Imidazo[1,2-a]pyridine Scaffold as Prospective Therapeutic Agents. Curr Top Med Chem. 2017;17(2):238-250. doi: 10.2174/1568026616666160530153233. PMID: 27237332.
14: Wang FJ, Xu H, Xin M, Zhang Z. Ι₂-mediated amination/cyclization of ketones with 2-aminopyridines under high-speed ball milling: solvent- and metal-free synthesis of 2,3-substituted imidazo[1,2-a]pyridines and zolimidine. Mol Divers. 2016 Aug;20(3):659-66. doi: 10.1007/s11030-016-9666-y. Epub 2016 Mar 14. PMID: 26975201.
15: Zhang Y, Chen Z, Wu W, Zhang Y, Su W. CuI-catalyzed aerobic oxidative α-aminaton cyclization of ketones to access aryl or alkenyl-substituted imidazoheterocycles. J Org Chem. 2013 Dec 20;78(24):12494-504. doi: 10.1021/jo402134x. Epub 2013 Dec 3. PMID: 24256374.
16: He C, Hao J, Xu H, Mo Y, Liu H, Han J, Lei A. Heteroaromatic imidazo[1,2-a]pyridines synthesis from C-H/N-H oxidative cross- coupling/cyclization. Chem Commun (Camb). 2012 Nov 21;48(90):11073-5. doi: 10.1039/c2cc35927h. Epub 2012 Sep 27. PMID: 23019572.
17: Katsura Y, Nishino S, Takasugi H. Studies on antiulcer drugs. I. Synthesis and antiulcer activities of imidazo[1,2-alpha]pyridinyl-2-oxobenzoxazolidines-3-oxo-2H-1,4-benzoxaz ines and related compounds. Chem Pharm Bull (Tokyo). 1991 Nov;39(11):2937-43. doi: 10.1248/cpb.39.2937. PMID: 1799940.
18: Melloni R, Melloni GF, Scarazatti E. Osservazioni sul comportamento dei valori ematici di PRL, TSH, FSH, LH NELLA malattia ulcerosa gastro-duodenale in trattamento farmacologico [Behavior of blood values of prolactin, TSH, FSH, and LH in gastroduodenal ulcer during drug therapy]. Boll Soc Ital Biol Sper. 1984 Apr 30;60(4):761-7. Italian. PMID: 6234007.
19: Parodi MC, Molinari F, Barocci S. Influence of 'cytoprotective' drugs (carbenoxolone, zolimidine, prostanoic acid) on mucus secretion in patients with gastric ulcer. Scand J Gastroenterol Suppl. 1984;92:163-6. PMID: 6234649.
20: Bombardelli E, Conti M, Magistretti MJ, Martinelli EM. Computer-aided evaluation of gastric proteoglycans by high-resolution gas chromatography. J Chromatogr. 1983 Nov 25;279:593-601. doi: 10.1016/s0021-9673(01)93662-3. PMID: 6672037.